english.prescrire.org > Prescrire International > N°253 - November 2023

n°253

November 2023

Issue Contents
Editorial

Free  Flexibility

p.255

Marketing Authorisations


Tebentafusp (Kimmtrak°) in metastatic uveal melanoma

p.257-259

Ciltacabtagene autoleucel (Carvykti°) in multiple myeloma after failure of several treatments

p.259

Venetoclax (Venclyxto°) as first-line treatment for chronic lymphocytic leukaemia, in combination with obinutuzumab

p.260-261

Trastuzumab deruxtecan (Enhertu°) in relapsed metastatic breast cancer with low HER2 overexpression

p.261

Editors' opinion. Changing the rules

p.262

Teriflunomide (Aubagio°) in multiple sclerosis from 10 years of age

p.262-263

Remdesivir (Veklury°) in covid-19 at increased risk of progression to severe disease, or in children on oxygen

p.263-264

Pembrolizumab (Keytruda°) in non-metastatic triple-negative breast cancer before and after surgery

p.265

Nivolumab (Opdivo°) as adjuvant treatment for certain urothelial carcinomas at high risk of recurrence

p.266

Cabozantinib (Cabometyx°) in differentiated thyroid cancer following another VEGF inhibitor

p.267

Adding daratumumab (Darzalex°) in relapsed or refractory multiple myeloma

p.268-269

Vutrisiran (Amvuttra°) in polyneuropathy associated with transthyretin amyloidosis

p.269

Filgotinib (Jyseleca°) in men: reassuring data on testicular function, but still dangerous

p.270

Adverse Effects


Intravenous drug administration: frequent errors

p.271

Biotin: misleading thyroid function test results

p.272

Dupilumab, tralokinumab: corneal disorders

p.273

Ivermectin: toxic epidermal necrolysis and Stevens-Johnson syndrome

p.273

Hydroxychloroquine in the first trimester of pregnancy: an increase in malformations

p.274

Carbamazepine: diplopia

p.274

Erenumab and other CGRP inhibitors: alopecia

p.275

Common stem: -gepant

p.275

Outlook


Evaluation of new drugs and medical devices in Europe: a highly critical report from the KCE

p.276-277

Taking a blood pressure-lowering drug in the evening: major uncertainty regarding the benefit

p.277-278

Free  Diclofenac: also harmful for the environment

p.278

Queries and Comments. When should levodopa be taken: with meals or between meals?

p.279

Masthead


Free  Masthead

p.254

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe